Cargando…
Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma
PURPOSE: Ultrasound nanobubbles (NBs) can kill tumor cells, mediated by their effects of cavitation and acoustic perforation through ultrasound, while as novel drug carriers, biomaterial-modified NBs release drugs at a target region. In this work, the ultrasound NBs bridged by biotin-streptavidin we...
Autores principales: | Chen, Yezi, Luo, Xiaoqin, Liu, Yun, Zou, Yunlei, Yang, Shiqi, Liu, Chaoqi, Zhao, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464779/ https://www.ncbi.nlm.nih.gov/pubmed/36105615 http://dx.doi.org/10.2147/IJN.S376172 |
Ejemplares similares
-
Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice
por: Tan, Yandi, et al.
Publicado: (2021) -
SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
por: Qiu, Tianyi, et al.
Publicado: (2023) -
Nanobubble-based anti-hepatocellular carcinoma therapy combining immune check inhibitors and sonodynamic therapy
por: Liu, Yun, et al.
Publicado: (2022) -
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015) -
The Different Colors of mAbs in Solution
por: Ambrogelly, Alexandre
Publicado: (2021)